Physician profile
Emily E Seal
NPI 1922381995
$5,405.48
in general payments reported to CMS, 2019-2025
11 companies · $2,426 in 2025
The $2,426 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $981 · 2022: $834 · 2023: $603 · 2024: $562 · 2025: $2,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,997 · Food and Beverage: $1,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,996.50 |
| Food and Beverage | $1,594.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $2,400.57 | 2022-2025 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $1,507.57 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $620.09 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $212.48 | 2021-2024 | Zepbound, Jardiance, Mounjaro |
| Sanofi-Aventis U.S. LLC | $206.06 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $122.67 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $104.14 | 2024-2025 | Tepezza, Repatha, Otezla |
| Corcept Therapeutics | $100.43 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $73.23 | 2021-2022 | |
| Medtronic, INC. | $35.42 | 2021-2023 | Minimed 780g |
| Dexcom, INC. | $22.82 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Seal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.